Developer docs
API playgroundTry for free, no card

Search company profiles

Nest.Bio Ventures

Full company profile

uuid0009o5n

Namestring
Nest.Bio Ventures
Legal namestring
Nest.Bio Labs
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Nest.Bio Ventures operates a biotech startup ecosystem in the Cambridge-Kendall Square corridor, comprising three interconnected offerings: Nest.Bio Labs, Hatch.Bio Labs, and the Nest.Bio Ventures investment arm. Nest.Bio Labs, founded in 2018 and headquartered at 100 Chestnut Street in Somerville, MA, provides BSL2+ certified shared and private laboratory space, office space, and shared equipment infrastructure (thermocyclers, qRT-PCR, plate readers, biosafety cabinets, centrifuges, microscopes, vivarium) to early-stage life sciences companies on flexible monthly subscription terms with no equity requirements. Hatch.Bio Labs, launched in 2024 as the next-generation expansion, adds private lab suites and amenity-rich space in a new Somerville facility. The Ventures arm takes a cross-border (North America/Asia) active-investment approach, partnering with pioneering founders to develop, fund, and commercialize ground-breaking biotech technologies in therapeutics, immunotherapy, synthetic biology, and precision medicine.

The company's revenue model combines recurring subscription income from lab and office rentals with venture equity participation in portfolio companies. Resident and graduate companies span diverse applications — glycopolymers (Fount Bio), HIV CAR-T therapy (IT Bio), sewage epidemiology (Biobot Analytics), single-cell drug discovery (HiFiBiO), genome editing (EdiGene), autophagy therapeutics (PAQ Therapeutics), Alzheimer's therapeutics (iNeuro Therapeutics), and biosensors (BioSens8). Go-to-market relies on organic community-building within the Cambridge/MIT/Harvard biotech ecosystem, supported by content marketing (Scientist Spotlight blog series), monthly community events, Lunch & Learn sessions with partners like MassBio (Edge Program partnership established May 2024), and direct site tours.

Nest.Bio reports scale metrics of 50+ resident and graduate companies, 1,029+ local jobs created by resident companies, >$7B in combined market cap value of alumni and residents, and >$2.5B collectively raised by alumni companies over 7 years. Leadership is led by James Weis (Partner, CEO of Nest.Bio Labs and Hatch.Bio Labs), with partners including Cheryl Cui and Daphne Teo (also CEO of NSG BioLabs), supported by venture partners, advisors (including Tim Lu), and operational staff. Ownership and cap table details are not publicly disclosed. The company is privately held with 11-50 employees and no disclosed funding rounds for the parent entity.

Short descriptiontext

Nest.Bio Ventures operates a Cambridge-area biotech startup ecosystem combining BSL2+ shared/private lab facilities (Nest.Bio Labs and Hatch.Bio Labs) with an active venture arm that takes a cross-border approach to funding and commercializing breakthrough life sciences companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
shared lab space, biotech incubator, venture capital, lab equipment leasing, life sciences facilities
Industry2 codes
1Accelerators & Incubators (Investor-Operated)
CodeFSANAAAMPrimaryYes
2Healthcare & Life Sciences Growth Equity
CodeFSANACABPrimaryNo
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Investment Advice6282
  • Services-Commercial Physical & Biological Research8731
Product category
Biotech Incubator Services
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Laboratory Space Rental
TypeSubscription Recurring
Description

Flexible leasing of shared and private BSL2+ laboratory bench space and wet lab suites to biotech startups. Revenue generated through monthly rental fees with flexible terms including single bench options to fully private suites.

nest.bio
2Office Space Rental
TypeSubscription Recurring
Description

Flexible office space leasing including open plan desks, private offices, and semi-private office neighborhoods. Amenities included such as reception services, conference rooms, and fully-equipped kitchens.

nest.bio
3Venture Investment Returns
TypeLicensing Royalties
Description

Active investment philosophy working alongside founding teams to translate high-impact science into therapies. Returns generated through equity participation in portfolio companies.

nest.bio
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Infrastructure, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Nest.Bio Ventures operates a biotech incubator ecosystem that provides shared and private BSL2+ laboratory and office space with flexible leasing (no equity requirements) to early-stage life sciences startups in the Cambridge-Somerville area. The company also runs a venture partnership program that invests in and supports pioneering biotech founders, helping develop, fund, and commercialize breakthrough technologies across therapeutics, diagnostics, and synthetic biology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 50+ companies in resident and graduate community
+3 more records
Product overview1 text field

Nest.Bio Ventures operates as a unified biotech ecosystem comprising three interconnected offerings: Nest.Bio Labs provides shared and private laboratory and office space for life science startups with flexible leasing and no equity requirements; Hatch.Bio Labs represents the next-generation facility expansion with private lab suites in a new Somerville location; and Nest.Bio Ventures delivers venture funding and partnership services to help develop, fund, and commercialize groundbreaking technologies. Together, these offerings support emerging biotech startups from early-stage research through commercialization, providing physical infrastructure, community, and capital.

Product and service3 records
1Nest.Bio Labs (Shared and Private Lab & Office Space)
CategoryBiotech incubator lab space
Description

Shared and private BSL2+ certified laboratory and office space rented on flexible monthly terms (no equity requirements) to early-stage life sciences startups in the Cambridge-Somerville biotech ecosystem. Includes shared equipment (thermocyclers, qRT-PCR, plate reader/washer, biosafety cabinets, incubators, microscopes, autoclave, fume hoods), vivarium, reception, conference rooms, kitchens, EHS training, lab permits, and chemical/biohazard waste removal.

2Hatch.Bio Labs (Next-Generation Private Lab Facility)
CategoryBiotech incubator lab space
Description

Next-generation private lab and office facility in Somerville, MA, offering BSL-2+ lab suites and flexible options from a single bench to fully private wet lab suites, with adjacent in-suite lab support rooms, board room, event space, reception, coffee shop, and cafe. Targets biotech startups seeking more dedicated lab environments while remaining in the Kendall Square ecosystem.

3Nest.Bio Ventures (Venture Partnership Program)
CategoryBiotech venture capital
Description

Active venture partnership program that works alongside pioneering biotech founders to develop, fund, and commercialize groundbreaking technologies, leveraging the firm's on-site support at the shared lab facilities. Bridges North America and Asia through cross-border company creation and draws on partners' expertise in machine learning, immunotherapy, and synthetic biology.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2024-05-24
Description

MassBio partnership provides Nest.Bio residents access to valuable networking events, extensive discounts with top vendors, and essential resources through the MassBio Edge Program. Nest.Bio hosts Lunch & Learn sessions with MassBio representatives to help resident biotech researchers access these benefits. Representatives Paul Cosgro and Callahan Johnson assist residents in finding resources.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cambridge, MA-based shared laboratory and office space provider for early-stage biotech startups, operating BSL-2 facilities in Kendall Square. Most direct geographic and product competitor to Nest.Bio Labs.

TypeDirect peer
Description

Operator of a national network of shared co-working lab facilities serving biotech startups across multiple US and European cities. Closest multi-site comparable to Nest.Bio/Hatch.Bio's lab-as-a-service model.

TypeDirect peer
Description

Provider of managed research environments combining core facility services with lab operations support for biotech tenants. Comparable in delivering turnkey lab infrastructure for resident companies.

TypeEmerging player
Description

Biotech-specific accelerator that takes equity and provides lab access, programming, and seed funding to early-stage biology startups. Comparable venture-adjacent incubator model with stronger investor-driven orientation.

TypeBroad incumbent
Description

Johnson & Johnson-operated global network of life sciences incubators offering no-strings-attached lab space to early-stage biotech startups. Directly comparable no-equity incubator model at much larger scale.

TypeBroad incumbent
Description

Large shared office and lab space operator in Kendall Square/Cambridge offering flexible memberships to startups across multiple sectors. Overlaps with Nest.Bio's office rental and broader community positioning.

TypeDirect peer
Description

San Carlos, CA-based shared lab and office space provider purpose-built for early-stage life sciences startups. Directly comparable in target customer and rental product offering.

TypeBroad incumbent
Description

Alexandria Real Estate's startup incubator arm offering shared lab and office space in major biotech clusters. Comparable product but backed by a much larger publicly traded REIT.

TypeDirect peer
Description

Asia-focused biotech incubator and shared lab operator; led by Daphne Teo, who is also a Partner at Nest.Bio Ventures. Highly comparable operating model with explicit US-Asia linkage.

TypeEmerging player
Description

Biotech accelerator and founder community that funds and supports early-stage life sciences startups. Comparable founder-support and community emphasis but with stronger venture funding orientation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment19 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nest.Bio Ventures

Biotech Incubator Servicesnest.bio

Nest.Bio Ventures operates a Cambridge-area biotech startup ecosystem combining BSL2+ shared/private lab facilities (Nest.Bio Labs and Hatch.Bio Labs) with an active venture arm that takes a cross-border approach to funding and commercializing breakthrough life sciences companies.

What Nest.Bio Ventures does

Nest.Bio Ventures operates a biotech startup ecosystem in the Cambridge-Kendall Square corridor, comprising three interconnected offerings: Nest.Bio Labs, Hatch.Bio Labs, and the Nest.Bio Ventures investment arm. Nest.Bio Labs, founded in 2018 and headquartered at 100 Chestnut Street in Somerville, MA, provides BSL2+ certified shared and private laboratory space, office space, and shared equipment infrastructure (thermocyclers, qRT-PCR, plate readers, biosafety cabinets, centrifuges, microscopes, vivarium) to early-stage life sciences companies on flexible monthly subscription terms with no equity requirements. Hatch.Bio Labs, launched in 2024 as the next-generation expansion, adds private lab suites and amenity-rich space in a new Somerville facility. The Ventures arm takes a cross-border (North America/Asia) active-investment approach, partnering with pioneering founders to develop, fund, and commercialize ground-breaking biotech technologies in therapeutics, immunotherapy, synthetic biology, and precision medicine.

The company's revenue model combines recurring subscription income from lab and office rentals with venture equity participation in portfolio companies. Resident and graduate companies span diverse applications — glycopolymers (Fount Bio), HIV CAR-T therapy (IT Bio), sewage epidemiology (Biobot Analytics), single-cell drug discovery (HiFiBiO), genome editing (EdiGene), autophagy therapeutics (PAQ Therapeutics), Alzheimer's therapeutics (iNeuro Therapeutics), and biosensors (BioSens8). Go-to-market relies on organic community-building within the Cambridge/MIT/Harvard biotech ecosystem, supported by content marketing (Scientist Spotlight blog series), monthly community events, Lunch & Learn sessions with partners like MassBio (Edge Program partnership established May 2024), and direct site tours.

Nest.Bio reports scale metrics of 50+ resident and graduate companies, 1,029+ local jobs created by resident companies, >$7B in combined market cap value of alumni and residents, and >$2.5B collectively raised by alumni companies over 7 years. Leadership is led by James Weis (Partner, CEO of Nest.Bio Labs and Hatch.Bio Labs), with partners including Cheryl Cui and Daphne Teo (also CEO of NSG BioLabs), supported by venture partners, advisors (including Tim Lu), and operational staff. Ownership and cap table details are not publicly disclosed. The company is privately held with 11-50 employees and no disclosed funding rounds for the parent entity.

Nest.Bio Ventures firmographics

Firmographics
Name
Nest.Bio Ventures
Legal name
Nest.Bio Labs
Website
https://nest.bio
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Nest.Bio Ventures operates a Cambridge-area biotech startup ecosystem combining BSL2+ shared/private lab facilities (Nest.Bio Labs and Hatch.Bio Labs) with an active venture arm that takes a cross-border approach to funding and commercializing breakthrough life sciences companies.
Ownership category
akta.pro rank

Nest.Bio Ventures industry classification

Industry
Product category
Biotech Incubator Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Investment Advice (6282), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Accelerators & Incubators (Investor-Operated) (FSANAAAM)
akta.pro secondary industry
Healthcare & Life Sciences Growth Equity (FSANACAB)

Keywords

  • Shared lab space
  • Biotech incubator
  • Venture capital
  • Lab equipment leasing
  • Life sciences facilities

Where Nest.Bio Ventures is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Nest.Bio Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Infrastructure, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Laboratory Space Rental: Flexible leasing of shared and private BSL2+ laboratory bench space and wet lab suites to biotech startups. Revenue generated through monthly rental fees with flexible terms including single bench options to fully private suites.
  2. Office Space Rental: Flexible office space leasing including open plan desks, private offices, and semi-private office neighborhoods. Amenities included such as reception services, conference rooms, and fully-equipped kitchens.
  3. Venture Investment Returns: Active investment philosophy working alongside founding teams to translate high-impact science into therapies. Returns generated through equity participation in portfolio companies.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Nest.Bio Ventures product offering

Product offering

Core offering

Nest.Bio Ventures operates a biotech incubator ecosystem that provides shared and private BSL2+ laboratory and office space with flexible leasing (no equity requirements) to early-stage life sciences startups in the Cambridge-Somerville area. The company also runs a venture partnership program that invests in and supports pioneering biotech founders, helping develop, fund, and commercialize breakthrough technologies across therapeutics, diagnostics, and synthetic biology.

Product overview

Nest.Bio Ventures operates as a unified biotech ecosystem comprising three interconnected offerings: Nest.Bio Labs provides shared and private laboratory and office space for life science startups with flexible leasing and no equity requirements; Hatch.Bio Labs represents the next-generation facility expansion with private lab suites in a new Somerville location; and Nest.Bio Ventures delivers venture funding and partnership services to help develop, fund, and commercialize groundbreaking technologies. Together, these offerings support emerging biotech startups from early-stage research through commercialization, providing physical infrastructure, community, and capital.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nest.Bio Labs (Shared and Private Lab & Office Space) Shared and private BSL2+ certified laboratory and office space rented on flexible monthly terms (no equity requirements) to early-stage life sciences startups in the Cambridge-Somerville biotech ecosystem. Includes shared equipment (thermocyclers, qRT-PCR, plate reader/washer, biosafety cabinets, incubators, microscopes, autoclave, fume hoods), vivarium, reception, conference rooms, kitchens, EHS training, lab permits, and chemical/biohazard waste removal.
  • Hatch.Bio Labs (Next-Generation Private Lab Facility) Next-generation private lab and office facility in Somerville, MA, offering BSL-2+ lab suites and flexible options from a single bench to fully private wet lab suites, with adjacent in-suite lab support rooms, board room, event space, reception, coffee shop, and cafe. Targets biotech startups seeking more dedicated lab environments while remaining in the Kendall Square ecosystem.
  • Nest.Bio Ventures (Venture Partnership Program) Active venture partnership program that works alongside pioneering biotech founders to develop, fund, and commercialize groundbreaking technologies, leveraging the firm's on-site support at the shared lab facilities. Bridges North America and Asia through cross-border company creation and draws on partners' expertise in machine learning, immunotherapy, and synthetic biology.

Quantifiable outcome

  • 50+ companies in resident and graduate community
  • +3 more outcomes

Companies that use Nest.Bio Ventures

Customer profile

Named customers14 records

Segments3 records

Ideal customer profiles2 records

Nest.Bio Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Nest.Bio Ventures partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MassBiocoreGTM or Marketing Partner · 24 May 2024MassBio partnership provides Nest.Bio residents access to valuable networking events, extensive discounts with top vendors, and essential resources through the MassBio Edge Program. Nest.Bio hosts Lunch & Learn sessions with MassBio representatives to help resident biotech researchers access these benefits. Representatives Paul Cosgro and Callahan Johnson assist residents in finding resources.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Nest.Bio Ventures competitors and assessment

Company assessment

Direct peers

  • LabCentral: Cambridge, MA-based shared laboratory and office space provider for early-stage biotech startups, operating BSL-2 facilities in Kendall Square. Most direct geographic and product competitor to Nest.Bio Labs.
  • BioLabs: Operator of a national network of shared co-working lab facilities serving biotech startups across multiple US and European cities. Closest multi-site comparable to Nest.Bio/Hatch.Bio's lab-as-a-service model.
  • SmartLabs: Provider of managed research environments combining core facility services with lab operations support for biotech tenants. Comparable in delivering turnkey lab infrastructure for resident companies.
  • MBC BioLabs: San Carlos, CA-based shared lab and office space provider purpose-built for early-stage life sciences startups. Directly comparable in target customer and rental product offering.
  • NSG BioLabs: Asia-focused biotech incubator and shared lab operator; led by Daphne Teo, who is also a Partner at Nest.Bio Ventures. Highly comparable operating model with explicit US-Asia linkage.

Emerging players

  • IndieBio: Biotech-specific accelerator that takes equity and provides lab access, programming, and seed funding to early-stage biology startups. Comparable venture-adjacent incubator model with stronger investor-driven orientation.
  • Petri (Petri.bio): Biotech accelerator and founder community that funds and supports early-stage life sciences startups. Comparable founder-support and community emphasis but with stronger venture funding orientation.

Broad incumbents

  • JLABS (Johnson & Johnson Innovation): Johnson & Johnson-operated global network of life sciences incubators offering no-strings-attached lab space to early-stage biotech startups. Directly comparable no-equity incubator model at much larger scale.
  • Cambridge Innovation Center (CIC): Large shared office and lab space operator in Kendall Square/Cambridge offering flexible memberships to startups across multiple sectors. Overlaps with Nest.Bio's office rental and broader community positioning.
  • Alexandria LaunchLabs: Alexandria Real Estate's startup incubator arm offering shared lab and office space in major biotech clusters. Comparable product but backed by a much larger publicly traded REIT.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Nest.Bio Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nest.Bio Ventures leadership team

Management profile

Number of profiles

Profiles9 records

Nest.Bio Ventures subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Nest.Bio Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nest.Bio Ventures M&A and investment

M&A and investment

M&A

Investments19 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nest.Bio Ventures

What does Nest.Bio Ventures do?

Nest.Bio Ventures operates a biotech incubator ecosystem that provides shared and private BSL2+ laboratory and office space with flexible leasing (no equity requirements) to early-stage life sciences startups in the Cambridge-Somerville area. The company also runs a venture partnership program that invests in and supports pioneering biotech founders, helping develop, fund, and commercialize breakthrough technologies across therapeutics, diagnostics, and synthetic biology.

Is Nest.Bio Ventures a public or private company?

Nest.Bio Ventures is a private company. It is classified as venture growth investor backed and is currently operating.

When was Nest.Bio Ventures founded?

Nest.Bio Ventures was founded in 2016. It employs 11 to 50 people.

Where is Nest.Bio Ventures based?

Nest.Bio Ventures is headquartered in Boston, United States, in the North America region.

How does Nest.Bio Ventures make money?

Three revenue lines are on record. Laboratory Space Rental is the primary driver. The others are office Space Rental and venture Investment Returns.

Who are Nest.Bio Ventures's main competitors?

Direct peers on record are LabCentral, BioLabs, SmartLabs, MBC BioLabs and NSG BioLabs. Emerging players are IndieBio and Petri (Petri.bio). Broad incumbents are JLABS (Johnson & Johnson Innovation), Cambridge Innovation Center (CIC) and Alexandria LaunchLabs.

Does Nest.Bio Ventures have an API?

No public API is recorded for Nest.Bio Ventures.

What industry is Nest.Bio Ventures in?

Nest.Bio Ventures's product category is Biotech Incubator Services. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated), with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 541714 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals